市場調査レポート
商品コード
1422804
自動放射線合成モジュール市場レポート:タイプ別、用途別、地域別、2024-2032年Automated Radiosynthesis Module Market Report by Type (Fully Automated, Semi-Automated), Application (Hospitals, Diagnostic Labs, Radiology Clinics, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
自動放射線合成モジュール市場レポート:タイプ別、用途別、地域別、2024-2032年 |
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
自動放射線合成モジュールの世界市場規模は、2023年に3,410万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに5,710万米ドルに達し、2024年から2032年の間に5.72%の成長率(CAGR)を示すと予測しています。様々な慢性疾患や心血管疾患、特に老年人口における有病率の増加、断層画像を作成するためのPETやSPECTスキャナに対する医療分野でのニーズの高まりや医療分野の進歩が、市場を牽引する主な要因となっています。
自動放射線合成モジュールとは、集中的な診断・治療手順の実行に適したトレーサー分子で放射性同位元素を調合するように設計された先進医療機器を指します。自動放射線合成モジュールは、陽電子放射断層撮影(PET)と単光子放射コンピュータ断層撮影(SPECT)スキャナーも採用しています。これらのソリューションは、断層画像診断法の有用性を向上させる。放射性トレーサーや放射性医薬品ユニットと比較すると、製造のカスタマイズ、装置寿命の延長、セットアップの利便性、診断や治療管理中の作業効率の向上が期待できます。これに加えて、自動放射線合成モジュールはすぐに使用でき、治療モニタリング活動を改善します。その結果、病院、研究所、診療所など、医療関係者に広く使用されています。現在、自動放射線合成モジュールは、全自動タイプと半自動タイプが市販されています。
がんや慢性閉塞性肺疾患(COPD)を含む様々な慢性疾患や心血管疾患の有病率の増加が、市場成長を促進する主要因となっています。また、断層画像を作成するためのPETやSPECTスキャナーのニーズが医療分野で高まっていることも、自動放射線合成モジュールの需要を促進しており、これも成長を促進する要因となっています。これに伴い、複数の政府が分散型環境での放射線トレーサーの生産に大規模な投資を行っていることも、市場の成長にさらに寄与しています。さらに、低資本コスト、最小限のインフラ要件、最適な性能など、複数の製品の利点に関する意識の高まりが、市場の成長を支えています。これはさらに、使用法、機能、効能の面で著しい技術進歩があり、市場成長にかなり有利になっているためと考えられます。さらに、慢性疾患にかかりやすい老年人口の増加や、世界の死亡率の上昇が市場成長を後押ししています。その他の要因としては、医療インフラの大幅な強化、最近の研究開発(R&D)活動、有効性を高めた代替新製品を開発するための主要企業間の主要な戦略的提携などがあり、市場成長に明るい見通しをもたらしています。また、医療産業の大幅な拡大や、さまざまな用途への自動放射線合成モジュールの採用を奨励するために政府や民間団体から提供される資金や助成金も、市場を牽引しています。
The global automated radiosynthesis module market size reached US$ 34.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.72% during 2024-2032. The increasing prevalence of various chronic and cardiovascular diseases, especially amongst the geriatric population, along with the rising need for PET and SPECT scanners in the healthcare sector to create tomographic images and advancements in the healthcare sector represent some of the key factors driving the market.
Automated radiosynthesis module refers to advanced medical equipment designed to formulate the radioactive isotope with a tracer molecule that is suitable to perform intensive diagnostic and therapeutic procedures. The automated radiosynthesis module also employs positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) scanners. These solutions improve the utility of tomographic imaging diagnostics methods. As compared to radiotracers and radiopharmaceutical units, it offers better scope for production customization, longer device life, setting-up convenience, and better operational efficiency while performing diagnosis and therapy administration. Along with this, the automated radiosynthesis module is readily usable and improves therapy monitoring activities. Consequently, it is extensively used across hospitals, laboratories, and clinics by healthcare practitioners. At present, automated radiosynthesis module is commercially available in full and semi-automated types.
The increasing prevalence of various chronic and cardiovascular diseases, including cancer and chronic obstructive pulmonary disorders (COPD), represents a prime factor driving the market growth. Additionally, the rising need for PET and SPECT scanners in the healthcare sector to create tomographic images have facilitated the demand for automated radiosynthesis module in the healthcare sector, which is acting as another growth-inducing factor. In line with this, the large-scale investments being made by several governments in the production of radiotracers in decentralized settings are further contributing to the market growth. Moreover, the rising awareness regarding the multiple product benefits, such as low capital cost, minimal infrastructural requirement, and optimal performance, is supporting the market growth. This can be further attributed to significant technological advancements in terms of its usage, features, and efficacy, which is considerably favoring the market growth. Additionally, the rising geriatric population, which is susceptible to chronic ailments, and the escalating mortality rates across the globe are propelling the market growth. Other factors, such as significant enhancements in the healthcare infrastructure, the recent research and development (R&D) activities, and the major strategic collaborations amongst key players to engineer new product alternatives with enhanced efficacy, are creating a positive outlook for the market growth. The market is also being driven by the significant expansion in the healthcare industry, along with funding and grants provided by government and private organizations to encourage the adoption of automated radiosynthesis module for various applications.
IMARC Group provides an analysis of the key trends in each segment of the global automated radiosynthesis module market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type and application.
Fully Automated
Semi-Automated
The report has also provided a detailed breakup and analysis of the automated radiosynthesis module market based on the type. This includes fully and semi-automated. According to the report, fully automated represented the largest segment.
Hospitals
Diagnostic Labs
Radiology Clinics
Others
A detailed breakup and analysis of the automated radiosynthesis module market based on the application has also been provided in the report. This includes hospitals, diagnostic labs, radiology clinics, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for automated radiosynthesis module. Some of the factors driving the North America automated radiosynthesis module market included the increasing prevalence of various chronic and cardiovascular diseases, significant technological advancements, and extensive research and development (R&D) activities.
The report has also provided a comprehensive analysis of the competitive landscape in the global automated radiosynthesis module market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Eckert & Ziegler Strahlen- und Medizintechnik AG, Elysia S.A., General Electric Company, IBA RadioPharma Solutions, Optimized Radiochemical Applications, SCINTOMICS Molecular, Applied Theranostics Technologies GmbH, Synthra GmbH, Trasis, etc.